Piscataway, NJ, March 23, 2023 – Camber Pharmaceuticals is pleased to announce the addition of Pantoprazole Sodium for Injection to its current portfolio.
Pantoprazole Sodium for Injection is indicated for short-term treatment (7 to 10 days) of adult patients with gastroesophageal reflux disease (GERD), a history of erosive esophagitis (EE), and pathological hypersecretion including Zollinger-Ellison Syndrome.
Pantoprazole Sodium for Injection is available in a carton of 10 single-dose vials each containing 40 mg of Pantoprazole freeze-dried powder for reconstitution. Learn more at www.camberpharma.com/products/pantoprazole-injectable
